IV infusion therapy
Slowing aging by design: the rise of NAD+ and sirtuin-activating compounds
Treatments involving NAD+ and its precursors, along with the sirtuin family (SIRT1-7) and sirtuin-activating compounds (STACs), show remarkable abilities to prevent disease and even reverse aspects of aging. These anti-aging compounds are shown to improve organ function, physical endurance, disease resistance, and longevity, while also treating inflammatory and metabolic disorders. These compounds are particularly notable in the longevity arena due to their ability to positively impact multiple systems and organs simultaneously.

Read more
